Survey of MeCP2 in the Rett syndrome and the non-Rett syndrome brain

Journal of Child Neurology

Volumn 18, Issue 10, 2003, Pages 683-687

  Armstrong, Dawna Duncan ^a   Deguchi, Kimiko ^a   Antallfy, Bobbie ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; PARAFFIN; PROTEIN ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; BRAIN CELL; BRAIN DEVELOPMENT; BRAIN NERVE CELL; BRAIN STEM; CARBOXY TERMINAL SEQUENCE; CELL COUNT; CELL POPULATION; CELL SELECTION; CHILD; CLINICAL ARTICLE; COILED BODY; CONTROLLED STUDY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; NERVE CELL PLASTICITY; ONTOGENY; PATHOPHYSIOLOGY; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETT SYNDROME; STEM CELL; SYNAPTIC TRANSMISSION; THALAMUS; TISSUE SECTION;

EID: 0242539771     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738030180100601     Document Type: Article

References (25)

1. Rett A: Cerebral atrophy associated with hyperammonemia, in Vinken PW, Bruyn GW (eds): Handbook of Clinical Neurology. Amsterdam, Oxford, 1977, 305-325.
2. Armstrong D, Kinney HC: The neuropathology of the Rett disorder, in Kerr A, Witt-Engerstrom I (eds): Rett Disorder and the Developing Brain. Oxford, UK, Oxford University Press, 2001, 58-84.
3. Schultz R, Glaze DG, Motil KJ, et al: The pattern of growth failure in Rett syndrome. Am J Dis Child 1993;147:633-637.
4. Nomura Y, Segawa M: Motor symptoms of the Rett syndrome: Abnormal tone, posture, locomotion and stereotyped movement. Brain Dev 1992;14(Suppl):S21-S28.
5. Kerr A, Witt-Engerstrom I: The clinical background of the disorder, in Kerr A, Witt-Engerstrom I (eds): Rett Disorder and the Developing Brain. Oxford, UK, Oxford University Press, 2001, 1-16.
6. Nielsen JB, Friberg L, Lou H, et al: Immature pattern of brain activity in Rett syndrome. Arch Neurol 1990;47:982-986.
7. Reiss AL, Faruque F, Naidu S, et al: Neuroanatomy of Rett syndrome: A volumetric imaging study. Ann Neurol 1993;34:227-234.
8. Armstrong D, Dunn JK, Schultz R, et al: Organ growth in Rett syndrome. Pediatr Neurol 1999;20:125-129.
9. Armstrong D: The neuropathology of the Rett syndrome. Brain Dev 1992;14(Suppl):S89-S98.
10. Bauman ML, Kemper TK, Arin DM: Microscopic observations of the brain Rett syndrome. Neuropediatrics 1995;26:105-108.
11. Belichenko PV: The morphologic substrate for communication, in Kerr A, Witt-Engerstrom I (eds): Rett Disorder and the Developing Brain. Oxford, UK, Oxford University Press, 2001, 277-302.
12. Armstrong D, Dunn JK, Antalffy B, Trivedi R: Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 1995;54:195-201.
13. Armstrong DD, Antalffy B, Dunn JK: Quantitative Golgi studies of dendrites in Rett syndrome and trisomy 21. J Neuropathol Exp Neurol 1996;55:630.
14. Zoghbi HY, Milstien S, Butler IJ, et al: Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome. Ann Neurol 1989;25:56-60.
15. Wenk GL, Naidu S, Casanova MF: Altered neurochemical markers; in Rett syndrome. Neurology 1991;41:1753-1756.
16. Wenk GI, O'Leary M, Nemeroff CB, et al: Neurochemical alterations in Rett syndrome. Dev Brain Res 1993;74:67-72.
17. Blue ME, Naidu S, Johnston MV: Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol 1999;45:541-545.
18. Deguchi K, Antalffy BA, Twohill LJ, et al: Substance P immunoreactivity in Rett syndrome. Pediatr Neurol 2000;22:259-266.
19. Engerstrom W, Forslund M: Mother and daughter with Rett syndrome, letter. Dev Med Child Neurol 1992;34:1022-1023.
20. Kaufmann WE: Cortical development in Rett syndrome: Molecular, neurochemical, and anatomical aspects, in Kerr A, Witt-Engerstrom I (eds): Rett Disorder and the Developing Brain. Oxford, UK, Oxford University Press, 2001, 85-110.
21. Shahbazian MD, Sun Y, Zoghbi HY: Balanced X chromosome inactivation patterns in the Rett syndrome brain. Am J Med Genet 2002;111:164-168.
22. Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY: Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 2002;11:115-124.
23. Amir RE, van den Veyver I, Wan M, et al: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23:185-188.
24. Lasalle JM, Goldstine J, Balmer D, Greco CM: Quantitative localization of heterogeneous methyl-CpG-binding protein2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser and scanning cytometry. Hum Mol Genet 2001;10:1729-1740.
25. Jung BP, Zhang G, Ho W, et al: Transient forebrain ischemia alters the mRNA expression of methyl DNA-binding factors in the adult rat hippocampus. Neuroscience 2002;115:515-524.